Introduction
Stem cells are promising tools for tissue regeneration.
Their remarkable ability in proliferation and differentiation enables them to restore the structures of impaired tissues. [1] The need to generate variety of tissues as well as the restriction of differentiation potential of stem cells after birth (compared with embryonic stem cells) have led to discovery of various resources of adult stem cells. [2] Various places in human body are colonized by considerable number of these cells, however, since access to these areas by surgery may cause damages to them, surgery would be considered as restricting factor in using these cells. For example, collecting these cells from the CNS causes deficiencies and problems that put the benefit of using these cells into question. On the other side, the selected locations should have a high percentage of stem cells compared with the amount of removed tissue.
The application of adult stem cells (ASCs) in tissue engineering is not followed by legal and ethical issues. Recently, most of ASCs are multipotent mesenchymal stromal cells (MSCs) [2] that have the capability of being transformed to different cells such as osteoblasts, [3] hepatocytes, [4] neurons, [5] adipocytes, cementoblasts, odontoblasts, [6] and cardiomyocytes. [7] These cells can make specific lesions heal through secretion of anti-inflammatory and nutrient materials.
The major source of ASCs is the bone marrow; however, they can be obtained from other reservoirs such as adipose tissue [1] and dental pulp. [12] and dental pulp stem cells (DPSCs). [8] [9] Moreover, based on a study, the DPSCs have been detected in hyperplastic pulpitis (pulp polyp), [13] since pulp polyp is characterized as a reactive lesion of oral cavity; it is likely to happen to other reactive lesions of oral cavity. Pyogenic granuloma is one of these lesions that are histopathologically similar to pulp polyp. Peripheral ossifying fibroma is another reactive lesion of oral cavity with a similar pathogenesis. To remove these lesions completely, both lesions are treated by excisional surgery. STRO-1 is a cell marker present on all clonogenic stromal precursors [14] and is most commonly used in stem cell researches as a reliable marker for mesenchymal stem cells. [15] [16] The aim of this study was to find clues on presence of dental mesenchymal stem cell (DMSCs) in these lesions, using an immunofluorescent technique to detect DMSC marker STRO-1. 
Materials and Method

Results
In this study, four pyogenic granulomas and four peripheral ossifying fibromas were studied. Table 1 represents the patients' demographic information. As- DMSCs are capable of forming dentin and pulp-like complex, and it makes the multipotent cells to be used as a perfect source for regenerating pulp and dental tissues. [23] Since the first researches, all types of dental mesenchymal stem cells have represented the ability to generate mineralized nodules with high levels of calcium when being placed in osteogenic culture medium, [15, 17, [24] [25] ] and the researchers have tested and confirmed their differentiation ability.
Cryoprotection of cells and tissues, especially in repair processes, has significantly improved recently.
[26] Up to now, only hematopoietic stem cells have been protected by cryoprotection [27] [28] and since then, 
